Immatics NV (IMTX)
6.52
-0.17
(-2.54%)
USD |
NASDAQ |
Nov 12, 16:00
6.51
-0.01
(-0.15%)
After-Hours: 20:00
Immatics Debt to Equity Ratio : 0.1079 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.1079 |
| June 30, 2026 | 0.0365 |
| March 31, 2026 | 0.0331 |
| December 31, 2025 | 0.0323 |
| September 30, 2025 | 0.0393 |
| June 30, 2025 | 0.0368 |
| March 31, 2025 | 0.0345 |
| December 31, 2024 | 0.0312 |
| September 30, 2024 | 0.0805 |
| June 30, 2024 | 0.0928 |
| March 31, 2024 | 0.0813 |
| December 31, 2023 | 0.1528 |
| September 30, 2023 | 0.1634 |
| June 30, 2023 | 0.1808 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.1224 |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 0.2443 |
| March 31, 2022 | 0.1775 |
| December 31, 2021 | 1.567 |
| September 30, 2021 | 0.9458 |
| June 30, 2021 | 0.0923 |
| March 31, 2021 | 0.0678 |
| December 31, 2020 | 0.2638 |
| September 30, 2020 | 0.0561 |
| June 30, 2020 | -0.1091 |
| March 31, 2020 | -0.0757 |
| December 31, 2019 | -0.0773 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| BioNTech SE | 0.0286 |
| MediGene AG | -- |
| InflaRx NV | 0.0056 |
| Twist Bioscience Corp. | 0.21 |
| Prime Medicine, Inc. | 2.825 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 642.58M |
| Total Liabilities (Quarterly) | 144.51M |
| Shareholders Equity (Quarterly) | 498.07M |
| Current Ratio | 5.025 |
| Net Debt Paydown Yield | -0.50% |